Biology Reference
In-Depth Information
17. Gorny MK, Zolla-Pazner S. (2000) Recognition by human mono-
clonal antibodies of free and complexed peptides representing the pre-
fusogenic and fusogenic forms of human immunodeficiency virus type 1
gp41.
J Virol
74
: 6186-6192.
18. Hansen JE, Clausen H, Nielsen C,
et al
. (1990) Inhibition of human
immunodeficiency virus (HIV) infection
in vitro
by anticarbohydrate mon-
oclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein
gp120 may be a target for virus neutralization.
J Virol
64
: 2833-2840.
19. Scanlan CN, Pantophlet R, Wormald MR,
et al
. (2002) The broadly
neutralizing anti-human immunodeficiency virus type 1 antibody
2G12 recognizes a cluster of alpha1
2 mannose residues on the
outer face of gp120.
J Virol
76
: 7306-7321.
20. Ugolini S, Mondor I, Parren PW,
et al
. (1997) Inhibition of virus
attachment to CD4
+
target cells is a major mechanism of T cell line-
adapted HIV-1 neutralization.
J Exp Med
186
: 1287-1298.
21. Liao HX, Alam SM, Mascola JR,
et al
. (2004) Immunogenicity of con-
strained monoclonal antibody A32-human immunodeficiency virus
(HIV) Env gp120 complexes compared to that of recombinant HIV
type 1 gp120 envelope glycoproteins.
J Virol
78
: 5270-5278.
22. Dimmock NJ. (1993) Neutralization of animal viruses.
Curr Top
Microbiol Immunol
183
: 1-149.
23. Ahmad A, Menezes J. (1996) Antibody-dependent cellular cytotoxic-
ity in HIV infections.
Faseb J
10
: 258-266.
24. Ahmad R, Sindhu ST, Toma E,
et al
. (2001) Evidence for a correla-
tion between antibody-dependent cellular cytotoxicity-mediating anti-
HIV-1 antibodies and prognostic predictors of HIV infection.
J Clin
Immunol
21
: 227-233.
25. Gomez-Roman VR, Cao C, Bai Y,
et al
. (2002) Phage-displayed
mimotopes recognizing a biologically active anti-HIV-1 gp120 murine
monoclonal antibody.
J Acquir Immune Defic Syndr
31
: 147-153.
26. Spear GT, Takefman DM, Sharpe S,
et al
. (1994) Antibodies to the
HIV-1 V3 loop in serum from infected persons contribute a major pro-
portion of immune effector functions including complement activa-
tion, antibody binding, and neutralization.
Virology
204
: 609-615.
27. Alsmadi O, Tilley SA. (1998) Antibody-dependent cellular cytotoxicity
directed against cells expressing human immunodeficiency virus type 1
envelope of primary or laboratory-adapted strains by human and chim-
panzee monoclonal antibodies of different epitope specificities.
J Virol
72
: 286-293.
→
